Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide (Q37262557)

19 August 2017

1 reference

title

Evidence-based dose-response assessment for thyroid tumorigenesis from acrylamide (English)

1 reference

19 August 2017

Michael Dourson

1

1 reference

19 August 2017

Richard Hertzberg

2

1 reference

19 August 2017

Bruce Allen

3

1 reference

19 August 2017

Lynne Haber

4

1 reference

19 August 2017

Ann Parker

5

1 reference

19 August 2017

Oliver Kroner

6

1 reference

19 August 2017

Andy Maier

7

1 reference

19 August 2017

Melissa Kohrman

8

1 reference

19 August 2017

language of work or name

English

0 references

publication date

20 August 2008

1 reference

Regulatory Toxicology and Pharmacology

19 August 2017

published in

1 reference

19 August 2017

volume

52

1 reference

19 August 2017

issue

3

1 reference

19 August 2017

page(s)

264-289

1 reference

The dose-response relationship at very low doses of acrylamide is linear in the flow cytometer-based mouse micronucleus assay

19 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Clastogenic effects of acrylamide in mouse bone marrow cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Development of screening tests for aneuploidy induction by environmental pollutants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Effect of acrylamide on neurotransmitter metabolism and neuropeptide levels in several brain regions and upon circulating hormones.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Correlation between carcinogenic potency of chemicals in animals and humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Dose-response modeling of in vivo genotoxicity data for use in risk assessment: some approaches illustrated by an analysis of acrylamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

The effects of acrylamide on mouse germ-line and somatic cell chromosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A review of mechanisms of acrylamide carcinogenicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Neurotransmitter receptors in brain regions of acrylamide-treated rats. II: Effects of extended exposure to acrylamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Arsenic interferes with the signaling transduction pathway of T cell receptor activation by increasing basal and induced phosphorylation of Lck and Fyn in spleen cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A classification framework and practical guidance for establishing a mode of action for chemical carcinogens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A comprehensive approach for integration of toxicity and cancer risk assessments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Tissue-specific genotoxic effects of acrylamide and acrylonitrile

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A nonlinear dosimetric model for hemoglobin adduct formation by the neurotoxic agent acrylamide and its genotoxic metabolite glycidamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Pathophysiology of chemical injury of the thyroid gland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide, an in vivo thyroid carcinogenic agent, induces DNA damage in rat thyroid cell lines and primary cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Cytogenetic effects of acrylamide in the bone marrow of mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Human respiratory tract cancer risks of inhaled formaldehyde: dose-response predictions derived from biologically-motivated computational modeling of a combined rodent and human dataset

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide: a review of its genotoxicity and an assessment of heritable genetic risk.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Estimation of systemic toxicity of acrylamide by integration of in vitro toxicity data with kinetic simulations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Effect of acrylamide on biogenic amine levels, monoamine oxidase, and cathepsin D activity of rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

DNA adducts derived from administration of acrylamide and glycidamide to mice and rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Risk assessment of acrylamide in foods

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Human exposure and internal dose assessments of acrylamide in food

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A review of the toxicology of acrylamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Metabolism and hemoglobin adduct formation of acrylamide in humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A Lifetime Oncogenicity Study in Rats with Acrylamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Toxicokinetics of acrylamide in humans after ingestion of a defined dose in a test meal to improve risk assessment for acrylamide carcinogenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Absence of acrylamide-induced genotoxicity in CYP2E1-null mice: evidence consistent with a glycidamide-mediated effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Predicting the carcinogenicity of chemicals in humans from rodent bioassay data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Xenobiotic-metabolizing cytochrome P450 enzymes in the human feto-placental unit: role in intrauterine toxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Thyroid follicular cell carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A prospective study of dietary acrylamide intake and the risk of endometrial, ovarian, and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Detection of chemical mutagens using Muta Mouse: a transgenic mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Enhancement by acrylamide of N-methyl-N-nitrosourea-induced rat mammary tumor development-possible application for a model to detect co-modifiers of carcinogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Chronic toxicity and oncogenicity study on acrylamide incorporated in the drinking water of Fischer 344 rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Human Hepatic CYP2E1 Expression during Development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

An interagency comparison of screening-level risk assessment approaches

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

CD57 (Leu-7) expression is helpful in diagnosis of the follicular variant of papillary thyroid carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Changes in thyroid gland morphology after acute acrylamide exposure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A physiologically based pharmacokinetic model for acrylamide and its metabolite, glycidamide, in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Mechanisms of acrylamide induced rodent carcinogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Mutagenic activity of acrylamide in eukaryotic systems but not in bacteria.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Upper confidence limits on excess risk for quantitative responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Genotoxicity of acrylamide and glycidamide in human lymphoblastoid TK6 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Cold thyroid nodules show a marked increase in proliferation markers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Subchronic acrylamide treatment induces a tissue-specific increase in DNA synthesis in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

In vitro binding of [14C]acrylamide to neurofilament and microtubule proteins of rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Assessment of the mutagenicity of dichloroacetic acid in lacI transgenic B6C3F1 mouse liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide neuropathy. III. Spatiotemporal characteristics of nerve cell damage in forebrain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Is estradiol a genotoxic mutagenic carcinogen?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Incorporation of pharmacokinetic and pharmacodynamic data into risk assessments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide inhibits dopamine uptake in rat striatal synaptic vesicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

DNA damage and DNA adduct formation in rat tissues following oral administration of acrylamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Genotoxicity of acrylamide and its metabolite glycidamide administered in drinking water to male and female Big Blue mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Thyroid gland neoplasia: non-genotoxic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

A framework for human relevance analysis of information on carcinogenic modes of action

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Mortality patterns among workers exposed to acrylamide: updated follow up.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Genotoxic effects of acrylamide and glycidamide in mouse lymphoma cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Dietary acrylamide and cancer of the large bowel, kidney, and bladder: absence of an association in a population-based study in Sweden

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Dietary acrylamide and risk of renal cell cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide intake and breast cancer risk in Swedish women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Prospective study of dietary acrylamide and risk of colorectal cancer among women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Validation studies with Muta™ mouse: A transgenic mouse model for detecting mutations in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Mutagenic and teratogenic effects of acrylamide in the mammalian spot test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide exposure and incidence of breast cancer among postmenopausal women in the Danish Diet, Cancer and Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide-induced cellular transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Induction of micronuclei in mouse and rat by glycidamide, genotoxic metabolite of acrylamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Dietary acrylamide and human cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

DNA strand breaking capacity of acrylamide and glycidamide in mammalian cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Weak genotoxicity of acrylamide on premeiotic and somatic cells on the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Formation of N-7-(2-carbamoyl-2-hydroxyethyl)guanine in DNA of the mouse and the rat following intraperitoneal administration of [14C]acrylamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Chemical mixtures from a public health perspective: the importance of research for informed decision making.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide: review of toxicity data and dose-response analyses for cancer and noncancer effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Mortality study update of acrylamide workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

In vivo transgenic mutation assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Acrylamide; induction of DNA damage, chromosomal aberrations and cell transformation without gene mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Autoclave sterilization produces acrylamide in rodent diets: implications for toxicity testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Developmental expression of CYP2E1 in the human liver. Hypermethylation control of gene expression during the neonatal period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Approaches to acrylamide physiologically based toxicokinetic modeling for exploring child-adult dosimetry differences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Cell proliferation and thyroid neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Mechanisms and pathogenesis of thyroid cancer in animals and man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

Physiologically based pharmacokinetic/pharmacodynamic model for acrylamide and its metabolites in mice, rats, and humans.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2008.08.004

10.1016/J.YRTPH.2008.08.004

7 January 2021

Identifiers

DOI

1 reference

19 August 2017

1 reference